Literature DB >> 33030828

Post-transplant lymphoproliferative disorders in a cohort of adult patients with a liver transplant from a reference hospital in Bogotá, Colombia

Leonardo F Jurado1, Andrés Gómez-Aldana2, Mónica Tapias3, Daniela Cáceres4, Alonso Vera5, Rocío Del Pilar López-Panqueva6, Rafael E Andrade7.   

Abstract

Introduction: The post-transplant lymphoproliferative disorders (PTLD) are characterized by an uncontrolled pathological lymphoid proliferation as a consequence of transplant immunosuppression therapy. Objective: To characterize the clinical and pathological characteristics of PTLD in a cohort of adult patients with liver transplant during a 15 year period at the Hospital Universitario Fundación Santa Fe de Bogota. Materials and methods: We conducted an observational retrospective study by searching for the PTLD cases diagnosed during the study period in the databases of the Liver Transplantation Unit and the Pathology Department. We collected the epidemiological, clinical, and pathological information and performed the corresponding statistics analyses.
Results: During the research period, 572 patients were transplanted; the incidence of PTDL was 2.44%; 79% of them were man and the average age at the time of diagnosis was 62.5 years; 71% of the cases were diagnosed during the first year after the transplant and the same percentage EBV-seropositive patients. The most frequent pathological phenotype was monomorphic and the majority of tumors was detected in the hepatic hilum. The one-year survival was 50%.
Conclusion: The high proportion of early cases and the high frequency of Epstein-Barr virus seropositivity both in donors and receptors drewour attention. More studies are necessary to have a better understanding of this condition in Colombia. This is the first PTLD clinical and pathological analysis in liver-transplant patients from Colombia to date.

Entities:  

Keywords:  Lymphoproliferative disorders; lymphoma; liver transplantation; Colombia

Year:  2020        PMID: 33030828      PMCID: PMC7666854          DOI: 10.7705/biomedica.4861

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  17 in total

1.  The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Authors:  M R Luskin; D S Heil; K S Tan; S Choi; E A Stadtmauer; S J Schuster; D L Porter; R H Vonderheide; A Bagg; D F Heitjan; D E Tsai; R Reshef
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

2.  Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

Authors:  S Caillard; C Lelong; F Pessione; B Moulin
Journal:  Am J Transplant       Date:  2006-11       Impact factor: 8.086

3.  Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.

Authors:  P B Doak; J Z Montgomerie; J D North; F Smith
Journal:  Br Med J       Date:  1968-12-21

4.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

5.  Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.

Authors:  Jennifer Trofe; Joseph F Buell; Thomas M Beebe; Michael J Hanaway; M Roy First; Rita R Alloway; Thomas G Gross; P Succop; E Steve Woodle
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

6.  Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.

Authors:  Khalid Mumtaz; Nabiha Faisal; Max Marquez; Alicia Healey; Leslie B Lilly; Eberhard L Renner
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-15

7.  Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States.

Authors:  V R Dharnidharka; K E Lamb; J A Gregg; H-U Meier-Kriesche
Journal:  Am J Transplant       Date:  2012-01-06       Impact factor: 8.086

Review 8.  Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?

Authors:  Daan Dierickx; Nina Cardinaels
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

9.  Impact of immunosuppression on the development of Epstein-Barr virus (EBV) viremia after pediatric liver transplantation.

Authors:  B R Lu; K T Park; M Hurwitz; K L Cox; W E Berquist
Journal:  Transplant Proc       Date:  2012-09-06       Impact factor: 1.066

10.  Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.

Authors:  A Kinch; L Cavelier; M Bengtsson; E Baecklund; G Enblad; C Backlin; U Thunberg; C Sundström; K Pauksens
Journal:  Am J Transplant       Date:  2014-10-10       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.